Jump to content
SCLERO.ORG
Sclero Forums

The Role of Fecal Calprotectin in Patients with Systemic Sclerosis (SSc) and Small Intestinal Bacterial Overgrowth (SIBO).


Recommended Posts

The Role of Fecal Calprotectin in Patients with Systemic Sclerosis (SSc) and Small Intestinal Bacterial Overgrowth (SIBO).

 

The development of SIBO in SSc patients, when associated with intense gastrointestinal symptoms and frequent diarrhoea often leads to malabsorption and malnutrition. PMC, Diagnostics (Basel), 2020 Aug; 10(8): 587. (Also see Bowel Dysfunction)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Link to post
Share on other sites
  • Joelf unpinned this topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...